Study Stopped
slow enrollment
Left Bundle Area Versus Selective His Bundle Pacing
LEFTBASH
1 other identifier
interventional
9
1 country
2
Brief Summary
This is a voluntary research study to find out which location in the heart a pacemaker wire is the most efficient for a patient's heart and for battery life. Patients who volunteer and are eligible for the study will be randomized to receive one of two positions for the wire to be screwed into, in addition to studying multiple positions in the heart during the pacemaker insertion. Enrolled patients will be in the study for 1 year. They will also have an Ultrasound of their heart performed to assess how the pacemaker wire is affecting their heart. Pacemakers are connected to the heart by wires that are screwed into the heart. The wires can be connected to the heart in different places, which can affect how well the heart beats over time. The typical position is at the tip of the heart. This position may cause the heart to beat inefficiently. Over time, this could lead to weakened heart muscle, irregular heart rhythm, and more hospitalizations. The heart has special muscle cells and fibers that carry electrical signals through and around the heart. An alternative spot to place the pacemaker wire is in an area where these special cells are grouped together (called the HIS bundle). The pacemaker wire can be connected to the heart at a location which may allow the heart to beat more efficiently when compared to putting the wire at traditional spots in the heart (called HIS bundle pacing). However, sometimes connecting the wire into the HIS bundle may cause the pacemaker battery to wear out faster. Physicians can also connect the pacemaker wired near the HIS bundle (called Left left Bundle bundle area pacing). The study physicians hope this will allow the heart to beat more efficiently without causing the battery to wear out faster. The study physicians would like to study how different wire positions change heart beat efficiency and how long the pacemaker battery lasts when the wires are placed in different locations. This study will connect the pacemaker wire at either the HIS Bundle or the left bundle area pacing, to see how effectively the heart pumps and how much battery is being used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2019
CompletedFirst Posted
Study publicly available on registry
September 18, 2019
CompletedStudy Start
First participant enrolled
October 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2022
CompletedResults Posted
Study results publicly available
August 17, 2022
CompletedAugust 17, 2022
June 1, 2022
2.4 years
September 16, 2019
June 9, 2022
July 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventricular Capture Threshold, 3 Months Unipolar or Bipolar
Ventricular capture threshold is the minimum amplitude of electrical signal from the pacemaker that consistently results in capture of the ventricular myocardium (normal contraction of the ventricle after electrical depolarization) with a 1.0 millisecond pulse width setting in unipolar or Bipolar output modes, measured in volts. During pacemaker placement, the ideal ventricular capture threshold is determined by delivering a series of pulses starting at 0.75 volts and increasing by 0.125 V with each trial until consistent ventricular contraction is achieved. Pacemaker settings are programmed using the ventricular capture threshold, adjusted to include a safety margin, and may be re-adjusted over time if clinically necessary. The measurement is automatically recorded within the pacemaker and will be interrogated from the pacemaker device at 3 months post implantation.
3 months
Secondary Outcomes (21)
Left Ventricular Ejection Fraction (LVEF) - Intrinsic Conduction
at index procedure prior to lead fixation
Stroke Volume - Intrinsic Conduction
at index procedure prior to lead fixation
Mechanical Dyssynchrony of Anterior Left Ventricle Myocardial Wall- Intrinsic Conduction
at index procedure prior to lead fixation
Mechanical Dyssynchrony of Inferior Left Ventricle Myocardial Wall- Intrinsic Conduction
at index procedure prior to lead fixation
Mechanical Dyssynchrony of Inferior-septal Left Ventricle Myocardial Wall- Intrinsic Conduction
at index procedure prior to lead fixation
- +16 more secondary outcomes
Study Arms (2)
Selective or Non selective His Bundle Pacing
ACTIVE COMPARATORPacemaker wires placed in Bundle of His
Left Bundle Area Pacing
ACTIVE COMPARATORPacemaker wires placed in Left Bundle Branch area
Interventions
A Select Secure pacing lead is placed in the bundle of His or Left bundle branch area based upon randomization
Eligibility Criteria
You may qualify if:
- Over 18 years old.
- With signed consent.
- Pacemaker indication according to 2018 American College of Cardiology/American Heart Association/Heart Rhythm Society Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay. With one or both of the following:
- Symptomatic sinus node dysfunction.
- Symptomatic Atrioventricular (AV) block or high degree AV block.
- Tachy-Brady syndrome
You may not qualify if:
- Previously implanted cardiac pacing devices except transvenous temporary pacemaker.
- Patients who are eligible for appropriate cardiac resynchronization therapy(CRT) or implantable cardiovert defibrillator (ICD) implantation
- Patients with prior septal myectomy
- Patients with prior surgical or transcatheter aortic valve replacement
- Anatomy precluding implant evaluated during the screening or identified during the procedure.
- Those without ability to achieve selective His bundle pacing evaluated during the screening or identified during the procedure
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- David Haines, MDlead
Study Sites (2)
Beaumont Health System
Royal Oak, Michigan, 48073, United States
Beaumont Health System
Troy, Michigan, 48085, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Early termination leading to small numbers of subjects and ECHO data not available for any subject.
Results Point of Contact
- Title
- Diedre Brunk
- Organization
- Beaumont Hospitals
Study Officials
- PRINCIPAL INVESTIGATOR
David Haines, MD
Beaumont
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director, Electrophysiology and Heart Rhythm Centre
Study Record Dates
First Submitted
September 16, 2019
First Posted
September 18, 2019
Study Start
October 7, 2019
Primary Completion
February 14, 2022
Study Completion
February 22, 2022
Last Updated
August 17, 2022
Results First Posted
August 17, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share